Skip to main content

Achieve Life Sciences Inc(ACHV-Q)

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Achieve Life Sciences Announces Appointment of Dr. Vaughn Himes to Board of Directors

Globe Newswire - Mon Mar 14, 2022

SEATTLE and VANCOUVER, British Columbia, March 14, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, is pleased to announce the appointment of Dr. Vaughn Himes to the company’s Board of Directors, effective immediately.


Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.